<DOC>
	<DOCNO>NCT00396097</DOCNO>
	<brief_summary>To demonstrate individualized , formula-based Genotropin regimen child Idiopathic Short Stature lead target height gain ( reach target 10th percentile ( % ) , -1.3 SDS ) 24 month treatment . The endpoint 4 year explore treatment efficiency four year two formula-based dose regimen ( sub-arms ) compare standard treatment</brief_summary>
	<brief_title>Individualized , Target-Driven Treatment Of Children With Idiopathic Short Stature</brief_title>
	<detailed_description />
	<mesh_term>Dwarfism</mesh_term>
	<criteria>Prepubertal child bone age 3 10 year age males 3 9 year age females Naive Growth Hormone treatment Abnormal karyotype . Small Gestational Age Skeletal dysplasia .</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>10 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>ISS</keyword>
	<keyword>human growth hormone</keyword>
</DOC>